146 related articles for article (PubMed ID: 15731166)
41. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
[TBL] [Abstract][Full Text] [Related]
42. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E
Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152
[TBL] [Abstract][Full Text] [Related]
43. Association of the NAD(P)H:quinone oxidoreductase (NQO1) 609C->T polymorphism with lung cancer risk among male smokers.
Lawson KA; Woodson K; Virtamo J; Albanes D
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2275-6. PubMed ID: 16172245
[No Abstract] [Full Text] [Related]
44. High risk of 'de novo' acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects.
Yamaguti GG; Lourenço GJ; Costa FF; Lima CS
Eur J Haematol; 2009 Sep; 83(3):270-2. PubMed ID: 19456854
[No Abstract] [Full Text] [Related]
45. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.
Yin L; Pu Y; Liu TY; Tung YH; Chen KW; Lin P
Lung Cancer; 2001; 33(2-3):133-41. PubMed ID: 11551408
[TBL] [Abstract][Full Text] [Related]
46. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
[TBL] [Abstract][Full Text] [Related]
47. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma.
Berndt SI; Huang WY; Chatterjee N; Yeager M; Welch R; Chanock SJ; Weissfeld JL; Schoen RE; Hayes RB
Carcinogenesis; 2007 Sep; 28(9):1965-70. PubMed ID: 17615257
[TBL] [Abstract][Full Text] [Related]
48. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.
Lafuente MJ; Casterad X; Trias M; Ascaso C; Molina R; Ballesta A; Zheng S; Wiencke JK; Lafuente A
Carcinogenesis; 2000 Oct; 21(10):1813-9. PubMed ID: 11023538
[TBL] [Abstract][Full Text] [Related]
49. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
[TBL] [Abstract][Full Text] [Related]
50. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
Takagi S; Kinouchi Y; Hiwatashi N; Hirai M; Suzuki S; Takahashi S; Negoro K; Obana N; Shimosegawa T
Anticancer Res; 2002; 22(5):2749-52. PubMed ID: 12529991
[TBL] [Abstract][Full Text] [Related]
51. Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE).
Bonaventure A; Goujon-Bellec S; Rudant J; Orsi L; Leverger G; Baruchel A; Bertrand Y; Nelken B; Pasquet M; Michel G; Sirvent N; Bordigoni P; Ducassou S; Rialland X; Zelenika D; Hémon D; Clavel J
Cancer Causes Control; 2012 Feb; 23(2):329-45. PubMed ID: 22200898
[TBL] [Abstract][Full Text] [Related]
52. DNA adducts and combinations of multiple lung cancer at-risk alleles in environmentally exposed and smoking subjects.
Peluso ME; Munnia A; Srivatanakul P; Jedpiyawongse A; Sangrajrang S; Ceppi M; Godschalk RW; van Schooten FJ; Boffetta P
Environ Mol Mutagen; 2013 Jul; 54(6):375-83. PubMed ID: 23797975
[TBL] [Abstract][Full Text] [Related]
53. Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.
Ouerhani S; Cherif N; Bahri I; Safra I; Menif S; Abbes S
Mol Biol Rep; 2013 Feb; 40(2):1307-14. PubMed ID: 23065291
[TBL] [Abstract][Full Text] [Related]
54. NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population.
Peng XE; Jiang YY; Shi XS; Hu ZJ
Gene; 2013 May; 521(1):105-10. PubMed ID: 23458878
[TBL] [Abstract][Full Text] [Related]
55. Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
Ali IU; Luke BT; Dean M; Greenwald P
Br J Cancer; 2005 Oct; 93(8):953-9. PubMed ID: 16205694
[TBL] [Abstract][Full Text] [Related]
56. Genotoxic impact of long-term cigarette and waterpipe smoking on DNA damage and oxidative stress in healthy subjects.
Alsaad AM; Al-Arifi MN; Maayah ZH; Attafi IM; Alanazi FE; Belali OM; Alhoshani A; Asiri YA; Korashy HM
Toxicol Mech Methods; 2019 Feb; 29(2):119-127. PubMed ID: 30273082
[TBL] [Abstract][Full Text] [Related]
57. Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
Daugherty SE; Platz EA; Shugart YY; Fallin MD; Isaacs WB; Chatterjee N; Welch R; Huang WY; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1536-42. PubMed ID: 17684125
[TBL] [Abstract][Full Text] [Related]
58. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
59. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
Wang XC; Wang J; Tao HH; Zhang C; Xu LF
Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
[TBL] [Abstract][Full Text] [Related]
60. NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer.
Harth V; Donat S; Ko Y; Abel J; Vetter H; Brüning T
Arch Toxicol; 2000 Jan; 73(10-11):528-31. PubMed ID: 10663383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
